21/05/2026
A New Frontier in Rheumatoid Arthritis Care
In 2025, a significant breakthrough emerged with the FDA's approval of the first neuroimmune modulation device for rheumatoid arthritis. This innovative device uses gentle electrical stimulation on the vagus nerve to help control inflammation, marking a pivotal shift in treatment approaches.
For the first time in decades, RA management has expanded beyond traditional immunosuppressant drugs to include targeted nerve stimulation. This represents a major advancement in how we approach autoimmune conditions, aligning with Singapore's embrace of medical technology and offering new hope for managing symptoms.
Staying informed about advancements in RA care is an important part of your journey. For personalised guidance on navigating your condition, the team at Aaria Rheumatology is here to support you.